High materiality7/10
Bicara Therapeutics Inc (BCAX) PT Raised to $39 at Morgan Stanley
Why it may matterVerify against the original reporting
Target upgrade; bullish setup
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Morgan Stanley raises price target to $39; current price $23.76.
- Target: $39
- Posted price: $23.76
- Analyst: Judah Frommer
- Firm: Morgan Stanley
Key facts
- 01
Target: $39
- 02
Posted price: $23.76
- 03
Analyst firm: Morgan Stanley
- 04
Analyst: Judah Frommer
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.